Methaemoglobinaemia in pregnancy with chronic kidney disease an uncommon case: A case report


GÖK M., Aydemir Y. G.

Journal of the Pakistan Medical Association, cilt.72, sa.2, ss.363-365, 2022 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 72 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.47391/jpma.3072
  • Dergi Adı: Journal of the Pakistan Medical Association
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.363-365
  • Anahtar Kelimeler: Methemoglobinemia, Prilocaine, Pregnancy, Hemodialysis
  • Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

The development of methaemoglobinaemia due to prilocaine, which is used for local anaesthesia, is a rare, life-threatening, but well-known side effect. The development of this side-effect in a pregnant patient with chronic kidney disease can lead to foetal distress. The case presented here is of a 21-year old pregnant female with chronic kidney disease who required haemodialysis in the 22nd week of pregnancy due to the progression to endstage kidney disease. During haemodialysis, a right jugular tunneled double-lumen catheter was inserted using prilocaine as the local anaesthetic. Prilocaineinduced methaemoglobinaemia was diagnosed. In the 24-hour follow-up, the methaemoglobin level decreased to normal with oxygen supply of 10-15 L/min, 2 units of erythrocyte suspension and accompanying haemodialysis.